Literature DB >> 23486291

Accessing the brain: the nose may know the way.

Per G Djupesland1, Ramy A Mahmoud, John C Messina.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23486291      PMCID： PMC3652706          DOI： 10.1038/jcbfm.2013.41

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  10 in total

1.  Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.

Authors:  Qingfeng Liu; Yehong Shen; Jie Chen; Xiaoling Gao; Chengcheng Feng; Lu Wang; Qizhi Zhang; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

Review 2.  Intranasal delivery of biologics to the central nervous system.

Authors:  Jeffrey J Lochhead; Robert G Thorne
Journal:  Adv Drug Deliv Rev       Date:  2011-11-15       Impact factor: 15.470

Review 3.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

4.  Uptake of exogenous proteins in mouse olfactory cells.

Authors:  K Kristensson; Y Olsson
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

5.  Anterior distribution of human olfactory epithelium.

Authors:  D A Leopold; T Hummel; J E Schwob; S C Hong; M Knecht; G Kobal
Journal:  Laryngoscope       Date:  2000-03       Impact factor: 3.325

6.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

7.  Direct access of drugs to the human brain after intranasal drug administration?

Authors:  Paul Merkus; Henk-Jan Guchelaar; D Andries Bosch; Frans W H M Merkus
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

Review 8.  Nasal saline irrigations for the symptoms of chronic rhinosinusitis.

Authors:  R Harvey; S A Hannan; L Badia; G Scadding
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

9.  Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review.

Authors:  Per Gisle Djupesland
Journal:  Drug Deliv Transl Res       Date:  2012-10-18       Impact factor: 4.617

Review 10.  Intranasal treatment of central nervous system dysfunction in humans.

Authors:  Colin D Chapman; William H Frey; Suzanne Craft; Lusine Danielyan; Manfred Hallschmid; Helgi B Schiöth; Christian Benedict
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200
  10 in total
  14 in total

Review 1.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

2.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

3.  Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.

Authors:  Haiyue Xu; Tinashe B Ruwona; Sachin G Thakkar; Yanping Chen; Mingtao Zeng; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

4.  Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.

Authors:  Y Pang; S Lin; C Wright; J Shen; K Carter; A Bhatt; L-W Fan
Journal:  Neuroscience       Date:  2016-01-14       Impact factor: 3.590

5.  Activation of cyclin D1 affects mitochondrial mass following traumatic brain injury.

Authors:  Pampa Saha; Rajaneesh Gupta; Tanusree Sen; Nilkantha Sen
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

6.  Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.

Authors:  Sachin G Thakkar; Zachary N Warnken; Riyad F Alzhrani; Solange A Valdes; Abdulaziz M Aldayel; Haiyue Xu; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2018-10-16       Impact factor: 9.776

7.  Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.

Authors:  D S Quintana; L T Westlye; Ø G Rustan; N Tesli; C L Poppy; H Smevik; M Tesli; M Røine; R A Mahmoud; K T Smerud; P G Djupesland; O A Andreassen
Journal:  Transl Psychiatry       Date:  2015-07-14       Impact factor: 6.222

8.  Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.

Authors:  D S Quintana; L T Westlye; S Hope; T Nærland; T Elvsåshagen; E Dørum; Ø Rustan; M Valstad; L Rezvaya; H Lishaugen; E Stensønes; S Yaqub; K T Smerud; R A Mahmoud; P G Djupesland; O A Andreassen
Journal:  Transl Psychiatry       Date:  2017-05-23       Impact factor: 6.222

9.  Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.

Authors:  Shweta Gupta; Rajesh Kesarla; Narendra Chotai; Ambikanandan Misra; Abdelwahab Omri
Journal:  Biomed Res Int       Date:  2017-01-23       Impact factor: 3.411

10.  Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans.

Authors:  D A Martins; N Mazibuko; F Zelaya; S Vasilakopoulou; J Loveridge; A Oates; S Maltezos; M Mehta; S Wastling; M Howard; G McAlonan; D Murphy; S C R Williams; A Fotopoulou; U Schuschnig; Y Paloyelis
Journal:  Nat Commun       Date:  2020-03-03       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.